These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma. Till BG Curr Treat Options Oncol; 2018 Jul; 19(9):45. PubMed ID: 30032463 [TBL] [Abstract][Full Text] [Related]
3. Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma. Telford C; Kabadi SM; Abhyankar S; Song J; Signorovitch J; Zhao J; Yao Z Clin Ther; 2019 Nov; 41(11):2357-2379.e1. PubMed ID: 31699438 [TBL] [Abstract][Full Text] [Related]
4. Treatment strategies in mantle cell lymphoma. Maddocks K; Blum KA Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613 [TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091 [TBL] [Abstract][Full Text] [Related]
9. Treatment of older patients with mantle cell lymphoma in the era of novel agents. Rozental A; Jim HSL; Extermann M Leuk Lymphoma; 2023 Sep; 64(9):1514-1526. PubMed ID: 37357622 [TBL] [Abstract][Full Text] [Related]
10. Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas. Puvvada SD; Guillen-Rodriguez J; Kumar A; Inclán L; Heard K; Rivera XI; Anwer F; Schatz JH; Mahadevan D; Persky DO Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):58-64. PubMed ID: 29056470 [TBL] [Abstract][Full Text] [Related]
12. Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation. Chen RW; Palmer JM; Tomassetti S; Popplewell LL; Alluin J; Chomchan P; Nademanee AP; Siddiqi T; Tsai NC; Chen L; Zuo F; Abary R; Cai JL; Herrera AF; Rossi JJ; Rosen ST; Forman SJ; Kwak LW; Holmberg LA J Hematol Oncol; 2018 Jun; 11(1):87. PubMed ID: 29954415 [TBL] [Abstract][Full Text] [Related]
13. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL). Dawar R; Hernandez-Ilizaliturri F Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454 [TBL] [Abstract][Full Text] [Related]